Literature DB >> 10428

Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse.

H E Shannon, S G Holtzman, D C Davis.   

Abstract

Interactions between the benzodiazepine derivatives, diazepam and oxazepam, and the narcotic analgesics, morphine and methadone, were evaluated on locomotor activity and in the tail-flick and hot-plate tests for analgesia in the mouse. The dose-related stimulation of locomotor activity by morphine was reduced by diazepam and oxazepam at doses which alone had no effect on locomotor activity. However, only oxazepam reduced the dose-related stimulation of locomotor activity by methadone. The observed decreases produced by diazepam and oxazepam were comparable in magnitude to those produced by naloxone. Stimulation of locomotor activity by d-amphetamine was not affected by either diazepam or oxazepam. Dose-response curves for locomotor activity were also determined with morphine and methadone administered intraventricularly. As before, diazepam and naloxone given i.p. decreased the stimulation of locomotor activity produced by morphine, but only naloxone affected methadone-stimulated locomotor activity. Neither diazepam, oxazepam nor naloxone reduced the brain or plasma levels of 3H-morphine or 3H-methadone. In contrast to the results on locomotor activity, neither of these benzodiazepines significantly modified the dose-response curves of morphine or methadone in either test for analgesia. The mechanisms involved in the observed interactions on locomotor activity may be related to the influences of benzodiazepines and narcotic analgesics on motor efferent pathways summating in such a manner as to interfere with the ability of the mice to locomote. The present results demonstrate that prominent interactions occur between members of the benzodiazepine and narcotic analgesic classes; these interactions are dependent upon both the specific combination of drugs administered and upon the test procedure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10428

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Morphine effects on activity and pain reactivity of developing mice with or without late prenatal oxazepam exposure.

Authors:  E Alleva; G Laviola; G Bignami
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Attenuation of reperfusion hyperalgesia in the rat by systemic administration of benzodiazepines.

Authors:  S M Cartmell; D Mitchell
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

3.  Modification of the antinociceptive effect of morphine by centrally administered diazepam and midazolam.

Authors:  P Mantegazza; M Parenti; R Tammiso; P Vita; F Zambotti; N Zonta
Journal:  Br J Pharmacol       Date:  1982-04       Impact factor: 8.739

4.  Benzodiazepine-opiate antagonism--a problem in intensive-care therapy.

Authors:  C F McDonald; S A Thomson; N C Scott; W Scott; I W Grant; G K Crompton
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

5.  Zopiclone potentiates the antinociceptive effect of morphine in rats.

Authors:  F Zambotti; N Zonta; R Tammiso; F Conci; B Hafner; P Ferrario; L Zecca; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

6.  Chlordiazepoxide antinociception: cross-tolerance with opiates and with stress.

Authors:  R J Bodnar; D D Kelly; L W Thomas; A Mansour; M Brutus; M Glusman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 7.  What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients.

Authors:  Angelo G I Maremmani; Matteo Pacini; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2019-02-03       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.